Lisa Miller | Senior Director, IR |
Rick Hawkins | CEO & Chairman |
Lori Lawley | CFO & Principal Accounting Officer |
David Karpf | Chief Medical Officer |
John McKew | Chief Scientific Officer & President |
Catherine Novack | Jones Trading |
Charles Duncan | Cantor Fitzgerald |
Leland Gershell | Oppenheimer |
Ed White | H.C. Wainwright & Co |
Yasmeen Rahimi | Piper Sandler |
Good afternoon, and welcome to Lumos Pharma's Q1 2023 Financial Results Conference Call. [Operator Instructions].
As a reminder, this conference call is being recorded.
I'll now turn the call over to Lisa Miller, Senior Director of Investor Relations.
Thank you, operator.